A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria
Clinical trial NCT03436797 · COMPLETED
Trial details
- NCT number
- NCT03436797
- Sponsor
- Allakos Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-23
- Primary completion
- 2018-11-21
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.